首页> 外文OA文献 >Furin-cleaved Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Is Active and Modulates Low Density Lipoprotein Receptor and Serum Cholesterol Levels

【2h】

Furin-cleaved Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Is Active and Modulates Low Density Lipoprotein Receptor and Serum Cholesterol Levels

机译：Furin-Creaved Proprotein转化酶枯草杆菌蛋白酶/ kexin型9（PCSK9）是活性的，并调节低密度脂蛋白受体和血清胆固醇水平

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Michael T. Lipari; Wei Li; Paul Moran; Monica Kong-Beltran; Tao Sai; Joyce Lai; S. Jack Lin; Ganesh Kolumam; Jose Zavala-Solorio; Anita Izrael-Tomasevic; David Arnott; Jianyong Wang; Andrew S. Peterson; Daniel Kirchhofer;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Furin-cleaved Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Is Active and Modulates Low Density Lipoprotein Receptor and Serum Cholesterol Levels [J] . Michael T. Lipari, Wei Li, Paul Moran, The Journal of biological chemistry . 2012,第52期

机译：Furin-Creaved Proprotein转化酶枯草杆菌蛋白酶/ kexin型9（PCSK9）是活性的，并调节低密度脂蛋白受体和血清胆固醇水平
2. Serum levels of proprotein convertase subtilisin/kexin type 9 in subjects with familial hypercholesterolemia indicate that proprotein convertase subtilisin/kexin type 9 is cleared from plasma by low-density lipoprotein receptor-independent pathways [J] . CameronJ., BogsrudM.P., TvetenK., Translational research: the journal of laboratory and clinical medicine . 2012,第2期

机译：家族性高胆固醇血症患者的血清原蛋白转化酶枯草杆菌蛋白酶/ kexin 9型水平表明通过低密度脂蛋白受体非依赖性途径从血浆中清除了原蛋白转化酶枯草杆菌蛋白酶/ kexin 9型
3. Reduction of low density lipoprotein- cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration [J] . Ference Brian A., Cannon Christopher P., Landmesser Ulf, European Heart Journal: The Journal of the European Society of Cardiology . 2018,第27期

机译：用Proprotein转化酶枯草杆菌蛋白酶-Kexin的低密度脂蛋白 - 胆固醇和心血管事件的减少9（PCSK9）抑制剂和他汀类药物：傅立叶，尖顶和胆固醇治疗试验专题的分析
4. Towards Investigating the Role of Proprotein Convertase Subtilisin/Kexin Family (PCSK/7/9) in Cancer by Using Bioinformatics Motif Detection Technique [C] . Umar Draz, Sana Yasin, Shafiq Hussain, International Bhurban Conference on Applied Sciences and Technologies . 2021

机译：通过使用生物信息学主题检测技术来研究Proprotein转化酶枯草杆菌素/ kexin家族（PCSK / 7/9）的作用
5. Evaluation of the Interaction Between Proprotein Convertase Subtilisin/Kexin Type 9 and Sterol Carrier Protein-2 [D] . Ahranjani, Reza. 2017

机译：评价前蛋白转化酶枯草杆菌蛋白酶/ Kexin 9型与甾醇载体蛋白2的相互作用。
6. Furin-cleaved Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Is Active and Modulates Low Density Lipoprotein Receptor and Serum Cholesterol Levels [O] . Michael T. Lipari, Wei Li, Paul Moran, 2012

机译：弗林蛋白酶切割的前蛋白转化酶枯草杆菌蛋白酶/ Kexin 9型（PCSK9）是活跃的并能调节低密度脂蛋白受体和血清胆固醇水平
7. Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is Independently Associated with Insulin Resistance, Triglycerides, Lipoprotein(a) Levels but not Low-Density Lipoprotein Cholesterol Levels in a General Population [O] . Hitoshi Hamamura, Hisashi Adachi, Mika Enomoto, 2021

机译：血清ProProtein转化酶枯草杆菌素/ kexin型9（PCSK9）与胰岛素抵抗，甘油三酯，脂蛋白（A）水平独立相关，但在一般人群中不是低密度脂蛋白胆固醇水平

Furin-cleaved Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Is Active and Modulates Low Density Lipoprotein Receptor and Serum Cholesterol Levels

著录项

引文网络

相似文献

相关主题

期刊订阅